Status:
COMPLETED
A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Acute Pain Following a Total Abdominal Hysterectomy
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of etoricoxib compared to placebo in the treatment of postoperative pain associated with total abdominal hysterectomy.
Eligibility Criteria
Inclusion
- Patients 18 years or older in generally good health who are scheduled to have a total hysterectomy and who are willing to limit alcohol consumption
Exclusion
- Patient is allergic to the study drug, other cyclooxygenase-2 (COX-2) inhibitors/nonsteroidal anti-inflammatory drugs (NSAIDS), ibuprofen, morphine, or oxycodone or has hypersensitivity to aspirin or other NSAIDS
- Patient has uncontrolled high blood pressure
- Patient has a history of drug and/or alcohol abuse within the last 5 years
- Patient has taken part in another investigational study within 4 weeks of the start of study
- Patient is breast-feeding
- Patient has an active ulcer or inflammatory bowel disease
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
430 Patients enrolled
Trial Details
Trial ID
NCT00788710
Start Date
October 1 2008
End Date
July 1 2010
Last Update
February 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.